Cell Model Passports - a hub for clinical, genetic and functional datasets of preclinical cancer models

Nucleic Acids Research

Volumn 47, Issue D1, 2019, Pages D923-D929

  Van Der Meer, Dieudonne ^a   Barthorpe, Syd ^a   Yang, Wanjuan ^a   Lightfoot, Howard ^a   Hall, Caitlin ^a   Gilbert, James ^a   Francies, Hayley E ^a   Garnett, Mathew J ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; CELL MODEL PASSPORTS DATABASE; COMPUTER ANALYSIS; DATA BASE; DISEASE MODEL; GENETIC DATABASE; INFORMATION PROCESSING; MALIGNANT NEOPLASM; MOLECULAR GENETICS; PRIORITY JOURNAL; STANDARDIZATION;

EID: 85059794862     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gky872     Document Type: Article

References (42)

1. Lynch, T.J., Bell, D.W., Sordella, R., Gurubhagavatula, S., Okimoto, R.A., Brannigan, B.W., Harris, P.L., Haserlat, S.M., Supko, J.G., Haluska, F.G. et al. (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.N. Engl. J. Med., 350, 2129-2139.
2. Chapman, P.B., Hauschild, A., Robert, C., Haanen, J.B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M. et al. (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med., 364, 2507-2516.
3. Shaw, A.T., Kim, D.-W., Nakagawa, K., Seto, T., Crinó, L., Ahn, M.-J., De Pas, T., Besse, B., Solomon, B.J., Blackhall, F. et al. (2013) Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.N. Engl. J. Med., 368, 2385-2394.
4. Brown, R.W. and Henderson, J.H. (1983) The mass production and distribution of HeLa cells at Tuskegee Institute, 1953-55. J. Hist. Med. Allied Sci., 38, 415-431.
5. Garnett, M.J., Edelman, E.J., Heidorn, S.J., Greenman, C.D., Dastur, A., Lau, K.W., Greninger, P., Thompson, I.R., Luo, X., Soares, J. et al. (2012) Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature, 483, 570-575.
6. Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A.A., Kim, S., Wilson, C.J., Lehár, J., Kryukov, G.V., Sonkin, D. et al. (2012) The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature, 483, 603-607.
7. Alley, M.C., Scudiero, D.A., Monks, A., Hursey, M.L., Czerwinski, M.J., Fine, D.L., Abbott, B.J., Mayo, J.G., Shoemaker, R.H. and Boyd, M.R. (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res., 48, 589-601.
8. Seashore-Ludlow, B., Rees, M.G., Cheah, J.H., Cokol, M., Price, E.V., Coletti, M.E., Jones, V., Bodycombe, N.E., Soule, C.K., Gould, J. et al. (2015) Harnessing connectivity in a Large-Scale Small-Molecule sensitivity dataset. Cancer Discov., 5, 1210-1223.
9. Gartler, S.M. (1968) Apparent Hela cell contamination of human heteroploid cell lines. Nature, 217, 750-751.
10. Nelson-Rees, W.A., Flandermeyer, R.R. and Hawthorne, P.K. (1974) Banded marker chromosomes as indicators of intraspecies cellular contamination. Science, 184, 1093-1096.
11. Lorsch, J.R., Collins, F.S. and Lippincott-Schwartz, J. (2014) Cell Biology. Fixing problems with cell lines. Science, 346, 1452-1453.
12. Luong, M.X., Auerbach, J., Crook, J.M., Daheron, L., Hei, D., Lomax, G., Loring, J.F., Ludwig, T., Schlaeger, T.M., Smith, K.P. et al. (2011) A call for standardized naming and reporting of human ESC and iPSC lines. Cell Stem Cell, 8, 357-359.
13. Vermeulen, S.J., Chen, T.R., Speleman, F., Nollet, F., Van Roy, F.M. and Mareel, M.M. (1998) Did the four human cancer cell lines DLD-1, HCT-15, HCT-8, and HRT-18 originate from one and the same patient? Cancer Genet. Cytogenet., 107, 76-79.
14. Kurtz, A., Seltmann, S., Bairoch, A., Bittner, M.-S., Bruce, K., Capes-Davis, A., Clarke, L., Crook, J.M., Daheron, L., Dewender, J. et al. (2018) A standard nomenclature for referencing and authentication of pluripotent stem cells. Stem Cell Rep., 10, 1-6.
15. Yu, M., Selvaraj, S.K., Liang-Chu, M.M.Y., Aghajani, S., Busse, M., Yuan, J., Lee, G., Peale, F., Klijn, C., Bourgon, R. et al. (2015) A resource for cell line authentication, annotation and quality control. Nature, 520, 307-311.
16. Behrens, I. and Kissel, T. (2003) Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? Eur. J. Pharm. Sci., 19, 433-442.
17. Ben-David, U., Siranosian, B., Ha, G., Tang, H., Oren, Y., Hinohara, K., Strathdee, C.A., Dempster, J., Lyons, N.J., Burns, R. et al. (2018) Genetic and transcriptional evolution alters cancer cell line drug response. Nature, 560, 325-330.
18. Iorio, F., Knijnenburg, T.A., Vis, D.J., Bignell, G.R., Menden, M.P., Schubert, M., Aben, N., Gonçalves, E., Barthorpe, S., Lightfoot, H. et al. (2016) A landscape of pharmacogenomic interactions in cancer. Cell, 166, 740-754.
19. Bairoch, A. (2018) The Cellosaurus, a Cell-Line Knowledge Resource. J. Biomol. Tech., 29, 25-38.
20. Forbes, S.A., Beare, D., Boutselakis, H., Bamford, S., Bindal, N., Tate, J., Cole, C.G., Ward, S., Dawson, E., Ponting, L. et al. (2017) COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res., 45, D777-D783.
21. Giard, D.J., Aaronson, S.A., Todaro, G.J., Arnstein, P., Kersey, J.H., Dosik, H. and Parks, W.P. (1973) In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst., 51, 1417-1423.
22. Cailleau, R., Olivé, M. and Cruciger, Q.V. (1978) Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro, 14, 911-915.
23. Ku, J.-L., Yoon, K.-A., Kim, I.-J., Kim, W.-H., Jang, J.-Y., Suh, K.-S., Kim, S.-W., Park, Y.-H., Hwang, J.-H., Yoon, Y.-B. et al. (2002) Establishment and characterisation of six human biliary tract cancer cell lines. Br. J. Cancer, 87, 187-193.
24. Yuan, Y., Kim, W.H., Han, H.S., Lee, J.H., Park, H.S., Chung, J.K., Kang, S.B. and Park, J.G. (1997) Establishment and characterization of cell lines derived from uterine malignant mixed Müllerian tumor. Gynecol. Oncol., 66, 464-474.
25. Ku, J.L., Kim, W.H., Lee, J.H., Park, H.S., Kim, K.H., Sung, M.W. and Park, J.G. (1999) Establishment and characterization of human laryngeal squamous cell carcinoma cell lines. Laryngoscope, 109, 976-982.
26. Park, J.G., Oie, H.K., Sugarbaker, P.H., Henslee, J.G., Chen, T.R., Johnson, B.E. and Gazdar, A. (1987) Characteristics of cell lines established from human colorectal carcinoma. Cancer Res., 47, 6710-6718.
27. Oh, J.H., Ku, J.L., Yoon, K.A., Kwon, H.J., Kim, W.H., Park, H.S., Yeo, K.S., Song, S.Y., Chung, J.K. and Park, J.G. (1999) Establishment and characterization of 12 human colorectal-carcinoma cell lines. Int. J. Cancer, 81, 902-910.
28. Turc-Carel, C., Philip, I., Berger, M.P., Philip, T. and Lenoir, G.M. (1984) Chromosome study of Ewing's sarcoma (ES) cell lines. Consistency of a reciprocal translocation t(11;22)(q24;q12). Cancer Genet. Cytogenet., 12, 1-19.
29. Phelps, R.M., Johnson, B.E., Ihde, D.C., Gazdar, A.F., Carbone, D.P., McClintock, P.R., Linnoila, R.I., Matthews, M.J., Bunn, P.A. Jr., Carney, D. et al. (1996) NCI-Navy Medical Oncology Branch cell line data base. J. Cell. Biochem. Suppl., 24, 32-91.
30. Drexler, H.G., Dirks, W.G., Matsuo, Y. and MacLeod, R.A.F. (2003) False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia, 17, 416-426.
31. Bady, P., Diserens, A.-C., Castella, V., Kalt, S., Heinimann, K., Hamou, M.-F., Delorenzi, M. and Hegi, M.E. (2012) DNA fingerprinting of glioma cell lines and considerations on similarity measurements. Neuro. Oncol., 14, 701-711.
32. Korch, C., Hall, E.M., Dirks, W.G., Ewing, M., Faries, M., Varella-Garcia, M., Robinson, S., Storts, D., Turner, J.A., Wang, Y. et al. (2018) Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line. Int. J. Cancer, 142, 561-572.
33. Capes-Davis, A., Theodosopoulos, G., Atkin, I., Drexler, H.G., Kohara, A., MacLeod, R.A.F., Masters, J.R., Nakamura, Y., Reid, Y.A., Reddel, R.R. et al. (2010) Check your cultures! A list of cross-contaminated or misidentified cell lines. Int. J. Cancer, 127, 1-8.
34. Masters, J.R., Thomson, J.A., Daly-Burns, B., Reid, Y.A., Dirks, W.G., Packer, P., Toji, L.H., Ohno, T., Tanabe, H., Arlett, C.F. et al. (2001) Short tandem repeat profiling provides an international reference standard for human cell lines. Proc. Natl. Acad. Sci. U.S.A., 98, 8012-8017.
35. Smirnov, P., Kofia, V., Maru, A., Freeman, M., Ho, C., El-Hachem, N., Adam, G.-A., Ba-Alawi, W., Safikhani, Z. and Haibe-Kains, B. (2018) PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies. Nucleic Acids Res., 46, D994-D1002.
36. Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., Jacobsen, A., Byrne, C.J., Heuer, M.L., Larsson, E. et al. (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov., 2, 401-404.
37. van de Wetering, M., Francies, H.E., Francis, J.M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L. et al. (2015) Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell, 161, 933-945.
38. Broutier, L., Mastrogiovanni, G., Verstegen, M.M., Francies, H.E., Gavarr ó, L.M., Bradshaw, C.R., Allen, G.E., Arnes-Benito, R., Sidorova, O., Gaspersz, M.P. et al. (2017) Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat. Med., 23, 1424-1435.
39. Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A.V., Wind, K., Gracanin, A., Begthel, H. et al. (2018) A living biobank of breast cancer organoids captures disease heterogeneity. Cell, 172, 373-386.
40. Tiriac, H., Belleau, P., Engle, D.D., Plenker, D., Deschênes, A., Somerville, T.D.D., Froeling, F.E.M., Burkhart, R.A., Denroche, R.E., Jang, G.-H. et al. (2018) Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discov., 8, 1112-1129.
41. Boj, S.F., Hwang, C.-I., Baker, L.A., Chio, I.I.C., Engle, D.D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M.S. et al. (2015) Organoid models of human and mouse ductal pancreatic cancer. Cell, 160, 324-338.
42. Nanki, K., Toshimitsu, K., Takano, A., Fujii, M., Shimokawa, M., Ohta, Y., Matano, M., Seino, T., Nishikori, S., Ishikawa, K. et al. (2018) Divergent routes toward Wnt and R-spondin niche independency during human gastric carcinogenesis. Cell, 174, 856-869.